{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:55:13Z","timestamp":1792716913287,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40261-024-01392-w","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T19:01:57Z","timestamp":1727550117000},"page":"733-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Calcipotriol and 5-Fluorouracil Combination Therapy for the Treatment of Actinic Keratosis in the Clinic: A Review Article"],"prefix":"10.1007","volume":"44","author":[{"given":"Anna H.","family":"Dlott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8690-4792","authenticated-orcid":false,"given":"Anthony J.","family":"Di Pasqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"4","key":"1392_CR1","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.jaad.2021.02.082","volume":"85","author":"DB Eisen","year":"2021","unstructured":"Eisen DB, Asgari MM, Bennett DD, et al. Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2021;85(4):e209\u201333. https:\/\/doi.org\/10.1016\/j.jaad.2021.02.082.","journal-title":"J Am Acad Dermatol"},{"key":"1392_CR2","unstructured":"Efudex (Fluorouracil). Package insert. Bridgewater: Bausch Heath; 2021."},{"key":"1392_CR3","unstructured":"Dovonex (Calcipotriene). Package insert. Menlo Park: Leo Laboratories; 2015."},{"issue":"2","key":"1392_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","volume":"84","author":"CA Elmets","year":"2021","unstructured":"Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021;84(2):432\u201370. https:\/\/doi.org\/10.1016\/j.jaad.2020.07.087.","journal-title":"J Am Acad Dermatol"},{"key":"1392_CR5","unstructured":"Fluorouracil (topical) [monograph]. In: Lexicomp Online [online database]. Wolters Kluwer. Updated May 17, 2024. https:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/1797301?cesid=77UlLVd2ThV&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3D5-fluorouracil%2Bcream%26t%3Dname%26acs%3Dtrue%26acq%3D5-fluo#monograph-tab-content. Accessed 6 June 2024."},{"key":"1392_CR6","unstructured":"Calcipotriene [monograph]. In: Lexicomp Online [database online]. Wolters Kluwer. Updated June 8, 2024. https:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6498?cesid=4zYqtYZrs6k&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dcalcipotriene%2Bcream%26t%3Dname%26acs%3Dtrue%26acq%3DCalcipotriene#monograph-tab-content. Accessed 16 June 2024."},{"issue":"4","key":"1392_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00403-024-02839-y","volume":"316","author":"P Patel","year":"2024","unstructured":"Patel P, Wang J, Bitterman D, Mineroff J, Austin E, Jagdeo J. Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy. Arch Dermatol Res. 2024;316(4):108. https:\/\/doi.org\/10.1007\/s00403-024-02839-y.","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"1392_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125476","volume":"4","author":"AR Rosenberg","year":"2019","unstructured":"Rosenberg AR, Tabacchi M, Ngo KH, et al. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention. JCI Insight. 2019;4(6): e125476. https:\/\/doi.org\/10.1172\/jci.insight.125476.","journal-title":"JCI Insight."},{"issue":"3","key":"1392_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2022.100104","volume":"2","author":"M Azin","year":"2022","unstructured":"Azin M, Mahon AB, Isaacman S, et al. Topical calcipotriol plus 5-fluorouracil immunotherapy for actinic keratosis treatment. JID Innov. 2022;2(3): 100104. https:\/\/doi.org\/10.1016\/j.xjidi.2022.100104.","journal-title":"JID Innov."},{"issue":"1","key":"1392_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1172\/JCI89820","volume":"127","author":"TJ Cunningham","year":"2017","unstructured":"Cunningham TJ, Tabacchi M, Eliane JP, et al. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. J Clin Investig. 2017;127(1):106\u201316. https:\/\/doi.org\/10.1172\/JCI89820.","journal-title":"J Clin Investig"},{"issue":"4","key":"1392_CR11","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jaad.2020.07.010","volume":"84","author":"AY Moore","year":"2021","unstructured":"Moore AY, Nguyen M, Moore S. Cyclic calcipotriene 0.005% foam and 1% 5-fluorouracil cream after cryotherapy in treatment of hyperkeratotic actinic keratosis: a retrospective study. J Am Acad Dermatol. 2021;84(4):1148\u201350. https:\/\/doi.org\/10.1016\/j.jaad.2020.07.010.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1392_CR12","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.3390\/ijms24054989","volume":"24","author":"D Arcuri","year":"2023","unstructured":"Arcuri D, Ramchatesingh B, Lagac\u00e9 F, et al. Pharmacological agents used in the prevention and treatment of actinic keratosis: a review. Int J Mol Sci. 2023;24(5):4989. https:\/\/doi.org\/10.3390\/ijms24054989.","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-024-01392-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-024-01392-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-024-01392-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:18:30Z","timestamp":1729700310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-024-01392-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1392"],"URL":"https:\/\/doi.org\/10.1007\/s40261-024-01392-w","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"4 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was received for the preparation of this article. Anthony J. Di Pasqua is supported financially by the Massachusetts College of Pharmacy and Health Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Anna H. Dlott and Anthony J. Di Pasqua have no conflicts of interest that are directly relevant to the content of this article. Sara A. Spencer is an employee of Otsuka Pharmaceutical.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AHD: conceptualization, original draft preparation, reviewing, and editing; SAS: reviewing and editing; AJD: conceptualization, reviewing, and editing.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}